Algeria vs Thailand: Cause of death, by non-communicable diseases, ages 15-59, male
Algeria
56.9%
in 2021
Thailand
56.6%
in 2021
Algeria rank
70th
Thailand rank
72nd
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Algeria
- Thailand
How they compare
Algeria currently reports 56.9% against 56.6% in Thailand, a difference of 0.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Algeria ahead.
Algeria ranks 70th and Thailand ranks 72nd of 185 countries.
Across the 3 decades both report, Algeria averaged higher in 2 and Thailand in 1.
Head to head by decade
| Decade | Algeria | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.3% | 30.8% | 22.5% | Algeria |
| 2010s | 63.8% | 51.2% | 12.6% | Algeria |
| 2020s | 47.5% | 57.8% | 10.3% | Thailand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Algeria or Thailand?
- Algeria, at 56.9% against 56.6% in Thailand as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Algeria and Thailand?
- 0.3%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Thailand?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Thailand rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Algeria ranks 70th and Thailand ranks 72nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.